AME - Educational Analysis * US Equities
Educational Analysis * US Equities

AME

Earnings behavior, post-earnings drift, and the gap between consensus and the market's real expectation - the educational primer before you look at the institutional verdict.

Educational content only - not investment advice. Nothing on this page is a recommendation to buy or sell any security. Historical patterns do not predict future outcomes. Consult a licensed financial advisor before making any trading decision.
Published byGamma QC editorial
TickerAME
CategoryEducational primer
Last reviewedNovember 16, 2026
You're viewing an older edition of this page.Read the latest edition →

Business Profile & Competitive Position

AMETEK, Inc. is an Industrials company classified under Electrical Equipment & Parts, operating as a global manufacturer of electronic instruments and electromechanical devices. The business is split into two segments: Electronic Instruments Group (EIG), which produces advanced analytical, test and measurement instruments for process, aerospace, power and industrial markets, and Electromechanical Group (EMG), which supplies precision motion control solutions, engineered medical components, thermal management systems, specialty metals and electrical interconnects. That product mix places AMETEK in a heavily B2B, specification-driven niche where customer relationships, engineering standards and regulatory certifications tend to create switching costs.

The margin and return figures support the idea that the company occupies a quality position rather than a commodity one. Its net margin of 19.9% and ROE of 14.7% are both well above what a typical low-differentiation electrical-components supplier would produce. A nearly 20% net margin suggests pricing power, cost discipline or some combination of proprietary design content, while a mid-teens ROE indicates management is generating respectable returns on the equity base. Paired with the mix of aerospace, defense, medical and automation exposure, these numbers imply a portfolio skewed toward engineered solutions rather than volume commodity parts.

Financial Posture

With a market capitalization of $55.5 billion, AMETEK sits at the large-cap end of the industrial universe. Its P/E ratio of 34.0 is elevated relative to many diversified industrials, reflecting either a scarcity premium for consistent execution or the market's willingness to pay up for what it treats as a compounder. The combination of a 19.9% net margin, 14.7% ROE and a beta of 0.97 frames the stock as a high-quality, relatively low-volatility name with a valuation that already embeds strong expectations.

That valuation matters when interpreting earnings reactions. At 34x trailing earnings, the stock is priced for continued strength. In practice, this means a reported EPS beat can be met with selling if guidance, margins or order commentary do not also clear a high bar. The financial posture is therefore strong in absolute terms but priced in a way that leaves limited room for merely meeting expectations.

Strategic Priorities & Outlook

AMETEK's most recent 10-K frames its strategy around the AMETEK Growth Model, which targets high-single-digit annual sales growth, double-digit annual EPS growth, strong cash-flow generation and a superior return on total capital. Those targets are reinforced by Operational Excellence initiatives including lean manufacturing, global sourcing, Design for Six Sigma, Value Engineering/Value Analysis, growth kaizens and the use of digitalization and artificial intelligence.

Acquisitions remain central to the playbook. From 2021 through December 31, 2025, AMETEK completed 15 acquisitions representing roughly $1.8 billion in annualized sales. In 2025 alone, the company spent $933.2 million in cash, net of cash acquired, to buy Kern (high-precision machining and optical inspection solutions) and FARO Technologies (3D measurement and imaging solutions). Geographic expansion is also a stated priority, with best-cost manufacturing facilities in China, Czechia, Malaysia, Mexico and Serbia supporting customer proximity and international growth.

Operationally, 2025 was a record year: sales reached $7,401.1 million, up 6.6% from 2024, while diluted EPS rose 7.9% to $6.40. The company also reported record operating income, net income, orders and backlog. With approximately 22,500 employees as of year-end, AMETEK continues to balance organic execution, M&A integration and global manufacturing scale.

Macro & Geopolitical Exposure

As an Electrical Equipment & Parts company with significant international operations, AMETEK is exposed to several macro themes. International sales represented 52% of EIG's net sales and 42% of EMG's net sales in 2025, which means currency translation, cross-border tariffs and regional growth differentials can all affect reported results. A stronger U.S. dollar would mechanically dampen overseas revenue conversion, while tariffs on components or finished goods could pressure costs or demand in key markets.

The sector also carries typical Industrials sensitivities: aerospace and defense budget cycles, capital-spending decisions by process and power customers, medical device regulation, and broad industrial automation demand. Commodity prices and supply-chain logistics can influence margin performance for EMG's specialty metals and interconnect products, while semiconductor and electronic-component availability can affect EIG's instrument production. In short, this is a cyclical-quality name with crosscurrents from trade policy, FX and global industrial demand.

Recent Developments

Recent headlines highlight both operational and governance updates. On November 11, 2026, defenseworld.net published a comparison of SMC and AMETEK. On November 9, 2026, zacks.com turned attention to AMETEK's international revenue trends and expectations, a relevant thread given the company's sizeable non-U.S. exposure. Also on November 9, 2026, AMETEK announced via prnewswire.com that it had promoted John Henriques and Kevin Coleman to Senior Vice Presidents. Earlier, on November 6, 2026, the company declared its quarterly dividend through another prnewswire.com release.

Earnings Behavior & Post-Earnings Drift

AMETEK has delivered a pristine earnings track record, beating estimates in all eight of the most recent reported quarters. The average earnings surprise across those quarters was 4.3%. Yet the market's response has been strikingly muted. The average five-day price move after earnings across those same quarters was -0.43%, classified as flat drift. That divergence between fundamental delivery and price reaction is the central lesson for anyone analyzing this stock around releases.

The last four quarters illustrate the pattern clearly. On November 3, 2026, AMETEK reported EPS of $2.21 against an estimate of $2.11, a 4.7% positive surprise, but the stock fell 4.62% the next day and 4.13% over the following five trading days. On August 4, 2026, EPS of $2.09 beat the $1.99 estimate by 5.0%, producing only a 0.28% next-day gain and a 0.89% five-day advance. On April 30, 2026, a 3.7% beat on $1.97 versus $1.90 was met with a 2.13% next-day drop and a 0.33% five-day decline. Even the February 3, 2026 report, where $2.01 beat $1.94 by 3.6%, saw a 0.48% next-day decline before drifting up 1.83% over five days.

What explains the disconnect? At 34 times earnings, AMETEK is priced for beats; the surprise itself may already be embedded in the stock before the report. The market's real expectation therefore often exceeds the published consensus, and forward commentary, margin trajectory, order rates and guidance can matter more than the headline EPS number. The next scheduled report is February 2, 2027 before the open, with a consensus EPS estimate of $2.28. Whether the stock reacts positively will likely depend not only on clearing that number but on whether the accompanying narrative justifies the premium already built into the share price.

Frequently Asked Questions

Why does AMETEK's stock sometimes fall after beating earnings estimates?

AMETEK has beaten estimates in 8 of the last 8 quarters, but at a P/E of 34.0 the market often prices in a beat before the release. When the unofficial consensus is higher than the published estimate, or when forward guidance, margins and orders do not exceed an elevated bar, the stock can sell off even after an EPS beat—as happened on November 3, 2026, when a 4.7% surprise accompanied a -4.62% next-day drop.

What are AMETEK's main strategic priorities?

The 10-K emphasizes the AMETEK Growth Model, which targets high-single-digit annual sales growth and double-digit annual EPS growth. Execution leans on Operational Excellence, strategic acquisitions (around $1.8 billion in annualized sales from 15 acquisitions from 2021 through 2025) and global expansion through facilities in China, Czechia, Malaysia, Mexico and Serbia.

What are the biggest macro risks for AMETEK shareholders?

International revenue exposure is significant: 52% of EIG sales and 42% of EMG sales went to customers outside the U.S. in 2025. That creates risk from currency translation, tariffs and regional industrial demand. Additional exposures include aerospace and defense budget cycles, medical device regulation, and commodity and supply-chain pressures affecting specialty metals and electrical components.

For a deeper dive into how institutional analysts are interpreting AMETEK's valuation, consensus positioning and upcoming catalysts, readers should review the full institutional verdict on the ticker page rather than relying on any single headline number.

Real Data - Gamma QC Earnings IntelligenceAs of Nov 16, 2026
AMETEK, Inc. · Industrials / Electrical Equipment & Parts
$55.5BMarket cap
34.0P/E
19.9%Net margin
14.7%ROE
100%Beat rate, last 8Q
4.3%Avg EPS surprise
-0.43%Avg 5-day move after earnings
2027-02-02Next earnings
ReportedActualEstimateSurprise1D Move5D Move
2026-11-03$2.21$2.11+4.7%-4.62%-4.13%
2026-08-04$2.09$1.99+5%+0.28%+0.89%
2026-04-30$1.97$1.9+3.7%-2.13%-0.33%
2026-02-03$2.01$1.94+3.6%-0.48%+1.83%
2025-10-30$1.89$1.76+7.4%--
2025-07-31$1.78$1.69+5.3%--

Previous AME editions

Beyond the primer

Get the institutional verdict on AME

Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.

Read the AME verdict at Gamma QC
$49 Pro / $249 RIA * gammaqc.com

Verify authenticity

Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.